Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]
News [2689]
Articles [196]
Editorials [1]
Conferences [135]
elearning [13]
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland...
Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers: Results from a phase II basket trial ( Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA )
11 Jun 2019
Mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2...
Dr Adrienne Waks - Dana-Farber Cancer Institute, Boston, USA
Mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2 mutated metastatic breast cancer ( Dr Adrienne Waks - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019
Updates in metastatic and early-stage breast cancer
Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
Updates in metastatic and early-stage breast cancer ( Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019
ADAPTCycle: Adjuvant personalised therapy comparing endocrine therapy plus...
Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany
ADAPTCycle: Adjuvant personalised therapy comparing endocrine therapy plus ribociclib versus chemotherapy in early breast cancer ( Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany )
11 Jun 2019
VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG...
Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG 0-1 and primarily non-resectable mCRC patients ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )
10 Jun 2019
SWOG 1314: A study of co-expression extrapolation (COXEN) with neoadjuvant...
Prof Thomas Flaig - University of Colorado Denver, Denver, USA
SWOG 1314: A study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for muscle-invasive bladder cancer ( Prof Thomas Flaig - University of Colorado Denver, Denver, USA )
10 Jun 2019
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive...
Prof Hope Rugo - University of California, San Francisco, USA
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive MBC after prior anti-HER2 therapies ( Prof Hope Rugo - University of California, San Francisco, USA )
10 Jun 2019
Breast cancer highlights from ASCO 2019
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer highlights from ASCO 2019 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
6 Jun 2019
ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in...
Dr William Tap - Memorial Sloan Kettering Cancer Center, New York, USA
ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcomas ( Dr William Tap - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jun 2019
Better education about breast cancer treatment in Africa
Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International...
Better education about breast cancer treatment in Africa ( Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana )
5 Jun 2019
The global program of the American Cancer Society
Dr Meg O'Brien - American Cancer Society, Atlanta, USA
The global program of the American Cancer Society ( Dr Meg O'Brien - American Cancer Society, Atlanta, USA )
5 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )
3 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation